Further down the line, a new edition of Raising the Bar - the book that comprehensively detailed the development of Half-Life 2 - will be released that includes information on the development of Episode 1 and 2 as well
Cagrilintide monotherapy for treatment of obesity In a 26-week phase 2 trial (n=706, 62 Percentage women, mean age 52 years), cagrilintide was evaluated in 5 groups of subjects receiving 0.3, 0.6, 1.2, 2.4, and 4.5 mg/week as treatment for obesity in comparison with liraglutide 3.0 mg/day, and placebo (table 1) [9]
It mimics ghrelin signaling at the pituitary, triggering sustained growth hormone release
The study was approved by the Institutional Review Board of Plastic Surgery Hospital, Chinese Academy of Medical Sciences, and the reference number for their judgment is IRB2024-364